Study Group: Disease Management Program Brokers(?)

Healthways reported lower than expected earnings in its current quarter and analysts are pointing to a tightening in the healthcare markets and the fact that Healthways products are expensive. Does this really make sense?

The passage of this bill by the Senate and the likely passage by the house are both good for consumers as well as the companies that conduct genetic testing.

The DOJ joins in when they have reviewed materials and believe it likely that there is a case with some civil or criminal violations.

Amerigroup is but one example of the increased scrutiny being paid to Medicaid Health Plans following the FBI raid of Wellcare last year. Expect this to continue and have some volatility on Medicaid health plan performance. Some of this scrutiny may uncover material issues, or impact contracting and...

Doctor Rating systems are here to stay and will play a greater role in contracting and patient decision making. Those that seek to disbelieve or dismiss these efforts may find themselves on the wrong end of this debate.  Even physician groups such as the American College of Surgeons and the American...